Regeneron, Sanofi win stay of order blocking cholesterol drug sales

(Reuters) - A U.S. appeals court on Wednesday has stayed an order that would have blocked Regeneron Pharmaceuticals Inc and Sanofi SA from selling their cholesterol drug, Praluent, later this month while they appeal.